Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents
Archiv der Pharmazie · 2023-08 · 356 (8)
DOI: 10.1002/ardp.202300054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 05.06.2023. Verfasst von Merve Bardakkaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkiye. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Arastirma Kurumu.
Themen: Demenz
Abstract (Originalsprache)
In this study, two diverse series of 2‐aminothiazole‐based multitarget compounds, one propenamide and the other propanamide derivatives, were designed and synthesized. Subsequently, their anticholinesterease and antioxidant (ORAC) activities were tested. Among them, compound 3e was the most potent acetylcholinesterase (AChE) inhibitor (AChE IC 50 = 0.5 μM, butyrylcholinesterase [BChE] IC 50 = 14.7 μM) and compound 9e was the most potent BChE inhibitor (AChE IC 50 = 3.13 μM, BChE IC 50 = 0.9 μM). Kinetic experiments showed that both compounds were mixed‐type inhibitors. According to the anticholinesterease activity results, five compounds ( 3e , 4e , 5e , 9d , and 9e ) were selected for further activity studies, all of which are dual cholinesterase inhibitors. Then, selected compounds were investigated in terms of their metal chelation activity. Moreover, their neuroprotective effects against H 2 O 2 ‐induced damage in the PC12 cell line were evaluated at 10 μM and the results showed that the neuroprotective effect of 3e was 53% compared with the reference ferulic acid (77%). 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) results of selected compounds revealed that the compounds were noncytotoxic. Additionally, 3e was more effective in reducing lipopolysaccharides‐induced interleukin‐1β (IL‐1β), IL‐6, tumor necrosis factor‐α (TNF‐α), and nitric oxide (NO) production in the human monocyte derived from patient with acute monocytic leukemia cell line compared with other selected compounds. Finally, a molecular docking study was also performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Biruni University, İstanbul, Turkiye.
- Department of Medical Biology, Faculty of Medicine, Uşak University, Uşak, Turkiye.
- Department of Chemistry, Faculty of Science, Hacettepe University, Ankara, Turkiye.
- Department of Analytical Chemistry, Faculty of Pharmacy, Kocaeli Health and Technology University, Kocaeli, Turkiye.
ORCID-Profile: Rahsan Ilıkcı Sagkan, Shakila Shakila
Förderung
- Türkiye Bilimsel ve Teknolojik Arastirma Kurumu
Zitieren
APA
Bardakkaya, M., Kilic, B., Sagkan, R. I., Aksakal, F., Shakila, S., & Dogruer, D. S. (2023). Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents. Archiv der Pharmazie, 356(8). https://doi.org/10.1002/ardp.202300054
Vancouver
Bardakkaya M, Kilic B, Sagkan RI, Aksakal F, Shakila S, Dogruer DS. Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents. Archiv der Pharmazie. 2023;356(8). doi:10.1002/ardp.202300054
BibTeX
@article{Bardakkaya2023,
author = {Bardakkaya, Merve and Kilic, Burcu and Sagkan, Rahsan Ilıkcı and Aksakal, Fatma and Shakila, Shakila and Dogruer, Deniz S},
title = {Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents},
journal = {Archiv der Pharmazie},
year = {2023},
volume = {356},
number = {8},
doi = {10.1002/ardp.202300054}
}
EUVIMED